Commentary: Valve options for ischemic mitral regurgitation in an era of new technologies: ViV(a) la bioprosthetic

J Thorac Cardiovasc Surg. 2023 Feb;165(2):646-647. doi: 10.1016/j.jtcvs.2021.02.076. Epub 2021 Feb 26.

Authors

Tomer Z Karas¹, Kevin D Accola²

Affiliations

¹ Cardiovascular Institute, AdventHealth Orlando, Orlando, Fla.
² Cardiovascular Institute, AdventHealth Orlando, Orlando, Fla. Electronic address: Kevin.Accola@AdventHealth.com.

PMID: 33785217
DOI: 10.1016/j.jtcvs.2021.02.076

No abstract available

Publication types

Editorial
Comment

MeSH terms

Bioprosthesis*
Heart Valve Diseases* / surgery
Heart Valve Prosthesis Implantation* / adverse effects
Heart Valve Prosthesis*
Humans
Mitral Valve Insufficiency* / diagnostic imaging
Mitral Valve Insufficiency* / etiology
Mitral Valve Insufficiency* / surgery
Prosthesis Failure
Treatment Outcome